Developer docs
API playgroundTry for free, no card

Search company profiles

Skezi

Full company profile

uuid0002rbi

Namestring
Skezi
Legal namestring
SKEZI
Websiteurl
skezi.eu
Company typeenum
Private
Founded yearint
2020
Descriptiontext

SKEZI is a French health-data software company that provides a sovereign SaaS platform for collecting and valorising patient-reported health data, founded in December 2020 as a spin-off from Assistance Publique-Hôpitaux de Paris (AP-HP) and Université Paris-Cité. Its core product, SKEZIA, is a HDS-certified (Hébergeur de Données de Santé) platform hosted on French infrastructure that enables the creation and management of e-cohorts, customizable questionnaires, and routine collection of Patient-Reported Outcome Measures (PROMs) and Patient-Reported Experience Measures (PREMs), with API interoperability into hospital information systems. The portfolio has expanded through two acquisitions: SKEMEET (formerly ShareConfrère, acquired April 2023), a tele-expertise platform for expert consultations, multidisciplinary consensus meetings (eRCP) and rare-disease workflow; and Verbatim.Care (acquired December 2024), an NLP-based patient verbatim analysis platform. SKETHIS, launched in 2023, is positioned as France's first health-related quality-of-life observatory at population scale.

SKEZI serves five primary customer segments: patient associations and advocacy groups; academic researchers running e-cohorts; hospitals and healthcare institutions pursuing Value-Based Healthcare programmes; pharmaceutical and medical-device companies running patient-centred clinical or post-marketing studies; and individual healthcare professionals. Anchor customers and design partners include AP-HP and Université Paris-Cité (co-founders and the ComPaRe/ESPERES cohorts), INRAE (Le French Gut national microbiome project, targeting 100,000 volunteers by 2027), UCB Pharma (SPOON study on myasthenia gravis), and Biogen (NewPerSEPtion study on multiple sclerosis). The platform reports 600,000+ patients involved, 20M+ data points collected, and 60+ peer-reviewed scientific publications.

The business model combines SaaS subscriptions for the SKEZIA and SKEMEET platforms (with tiered service levels and the SKEZIA+ enhanced-service offering) and professional services for study design, regulatory compliance, and implementation. Distribution is hybrid: direct enterprise sales to hospitals, pharma and academic institutions, plus a self-serve free-beta access channel for smaller researchers, associations, and individual clinicians. The company is headquartered in Annecy with a Paris office, has 11–50 employees, and is privately held; the only disclosed funding event is a Bpifrance round of approximately $2.73M in November 2024, supplemented by EU co-funding.

Short descriptiontext

SKEZI is a French health-data SaaS provider, spun out of AP-HP and Université Paris-Cité in 2020, offering a sovereign, HDS-certified platform (SKEZIA) for e-cohort management, PROMs/PREMs collection, and patient-reported research serving hospitals, academics, pharma, and patient associations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAnnecy, France
HQ citystring
Annecy
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research software, health data collection, electronic patient cohorts, patient reported outcomes, tele-expertise platform
Industry2 codes
PRIMARYHLACAOAB
eCOA/ePRO/eDiary & Patient-Facing Data Collection
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Clinical Research Software (Health Data Collection & E-Cohort Management)
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Software Subscriptions (SKEZIA/SKEMEET)
TypeSubscription Recurring
Description

SaaS platform subscriptions for data collection, e-cohort management, and tele-expertise services with tiered service levels

skezi.eu
2Professional Services
TypeProfessional Services
Description

Expert support for study design, regulatory compliance, and implementation assistance for healthcare research projects

skezi.eu
3SKEZIA+ Service
TypeSubscription Recurring
Description

Enhanced service offering with individualized support for complex data collection projects

skezi.eu
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1SKEZIA
Description

Platform for collecting sensitive and secure health data via questionnaires, including e-cohort management and survey tools.

skezi.eu
+3 more records
Core offering1 text field

Skezi (commercial name: SKEZI) sells the SKEZIA SaaS platform, a sovereign French health data collection solution that enables clinical researchers, healthcare institutions, pharmaceutical companies, and patient associations to build and manage electronic patient cohorts (e-cohorts) and collect patient-reported outcomes (PROMs/PREMs) via customizable questionnaires. The company complements SKEZIA with SKEMEET tele-expertise software, SKETHIS quality-of-life observatory services, and Verbatim.Care NLP-based patient verbatim analysis.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 600,000+ patients involved in platform studies
+3 more records
Product overview1 text field

SKEZI offers a suite of e-health data collection solutions centered around its core platform SKEZIA. SKEZIA is the primary sovereign SaaS product for collecting secure health data via questionnaires, managing e-cohorts, and supporting PROMs/PREMs collection. This core platform is complemented by SKEMEET (formerly ShareConfrère), a tele-expertise platform for expert consultations and multidisciplinary meetings; Verbatim.Care, an NLP-powered patient verbatim analysis platform acquired from EntendsMoi; and SKETHIS, a quality-of-life observatory initiative. Together, these products form a 360° health data collection ecosystem spanning clinical research, routine care, patient experience, and public health monitoring.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-10-16
Description

SKEZI deploying SKEZIA for Le French Gut national project, aiming to collect microbiome samples and data from 100,000 volunteers by 2027 to map French gut microbiota and understand chronic disease interactions

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-founding partner of SKEZI spin-off, continuing development of ComPaRe cohort technology and academic research collaboration

Strategic tierStrategicTypeTechnology or Integration
Description

Partnership for remote patient monitoring combining Withings connected health devices with SKEZI data collection platform for hypertension management, enabling pharmacists to relay patient data

Strategic tierStrategicTypeGTM or Marketing Partner
Description

SKEZI joined OVHcloud Startup Program for one year, receiving infrastructure support and recognition as Health Startup of the Year 2022

Strategic tierStrategicTypeTechnology or Integration
Description

Partnership for data anonymization using Octopize's unique technology to protect SKETHIS community data while preserving useful information for research

Strategic tierMinorTypeGTM or Marketing Partner
Description

Partnership for recruiting professionals with scientific and medical competencies to support SKEZI team growth

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Partnership with leading kidney disease patient association to accelerate research and care evaluation using SKEZIA for data collection and e-cohort monitoring

8Club des Jeunes Néphrologues (CJN)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership enabling all CJN members to access SKEZIA for independent studies and data collection to accelerate kidney disease research

skezi.eu
9AGORiA Santé
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership to improve healthcare through better health data exploitation, accelerating patient-reported data collection for AGORIA's health data warehouse

skezi.eu
10UCB Pharma
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Pharmaceutical partner for SPOON study on generalized myasthenia gravis, funded by UCB to understand patient quality of life and treatment expectations

skezi.eu
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

NewPerSEPtion study on perceived value of natalizumab treatment in multiple sclerosis patients, with SKEZI handling regulatory documents, data collection platform, and analysis

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnership with gaming/animation school to integrate gamification into e-health solution, making data collection more engaging

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Co-construction of patient feedback collection and liver disease research, including 'Juin sans sucres ajoutés' initiative

14Alliance PEP Santé
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with national healthcare platform supporting patient and caregiver accompaniment through SKEZIA availability

skezi.eu
Strategic tierStrategicTypeTechnology or Integration
Description

Acquisition of EntendsMoi platform (Verbatim.Care) in December 2024 to strengthen SKEZIA with patient verbatim analysis and NLP capabilities

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-founding partner and primary research institution behind ComPaRe and ESPERES cohorts, largest hospital system in Europe

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
1Doctolib
TypeRegional player
Description

Doctolib is the dominant French health-tech platform used by hospitals and physicians; it is not a direct eCOA competitor but shapes the French procurement landscape in which SKEZI sells its interoperable e-health platform.

TypeBroad incumbent
Description

Clario (formerly ERT/Bioclinica) is a large incumbent in clinical trial endpoint technology, including eCOA — providing the bundled alternative SKEZI competes against for hospital and pharma trials.

TypeDirect peer
Description

Signant Health is a global eCOA/ePRO specialist focused on patient-reported outcomes in clinical trials — the same core problem SKEZI addresses, with deeper enterprise pharma coverage.

TypeEmerging player
Description

THREAD is a decentralized clinical trial platform with eCOA/ePRO modules — overlapping SKEZI's decentralized patient data collection, though focused on global pharma rather than French institutional cohorts.

TypeEmerging player
Description

Alira Health provides patient-centric real-world evidence and outcomes services for medtech and pharma — overlapping SKEZI's PRO/ePRO-based evidence generation value proposition.

TypeEmerging player
Description

Owkin is a French health-AI company working on real-world patient data for research — thematically adjacent to SKEZI's cohort and RWE focus within the French health-data ecosystem.

TypeEmerging player
Description

Curebase runs decentralized and hybrid clinical trials with built-in ePRO/eCOA, an emerging alternative for sponsors comparing site-less trial designs against e-cohort-based approaches like SKEZIA.

TypeDirect peer
Description

Castor is a direct competitor in eCOA/ePRO and electronic data capture for clinical trials, offering a self-service clinical research platform widely adopted by academic and commercial sponsors — directly overlapping SKEZI's SKEZIA offering.

TypeBroad incumbent
Description

Cegedim is a French health-data and clinical-research software incumbent (THINK, Clinityx) operating across real-world evidence and hospital information systems — overlapping with SKEZI's hospital interoperability play.

TypeBroad incumbent
Description

Medidata's Rave platform bundles EDC, eCOA, and patient-reported outcomes in one enterprise stack, making it the dominant broad incumbent competing for the same pharma-sponsored PRO data workloads.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Skezi

Clinical Research Software (Health Data Collection & E-Cohort Management)skezi.eu

SKEZI is a French health-data SaaS provider, spun out of AP-HP and Université Paris-Cité in 2020, offering a sovereign, HDS-certified platform (SKEZIA) for e-cohort management, PROMs/PREMs collection, and patient-reported research serving hospitals, academics, pharma, and patient associations.

What Skezi does

SKEZI is a French health-data software company that provides a sovereign SaaS platform for collecting and valorising patient-reported health data, founded in December 2020 as a spin-off from Assistance Publique-Hôpitaux de Paris (AP-HP) and Université Paris-Cité. Its core product, SKEZIA, is a HDS-certified (Hébergeur de Données de Santé) platform hosted on French infrastructure that enables the creation and management of e-cohorts, customizable questionnaires, and routine collection of Patient-Reported Outcome Measures (PROMs) and Patient-Reported Experience Measures (PREMs), with API interoperability into hospital information systems. The portfolio has expanded through two acquisitions: SKEMEET (formerly ShareConfrère, acquired April 2023), a tele-expertise platform for expert consultations, multidisciplinary consensus meetings (eRCP) and rare-disease workflow; and Verbatim.Care (acquired December 2024), an NLP-based patient verbatim analysis platform. SKETHIS, launched in 2023, is positioned as France's first health-related quality-of-life observatory at population scale.

SKEZI serves five primary customer segments: patient associations and advocacy groups; academic researchers running e-cohorts; hospitals and healthcare institutions pursuing Value-Based Healthcare programmes; pharmaceutical and medical-device companies running patient-centred clinical or post-marketing studies; and individual healthcare professionals. Anchor customers and design partners include AP-HP and Université Paris-Cité (co-founders and the ComPaRe/ESPERES cohorts), INRAE (Le French Gut national microbiome project, targeting 100,000 volunteers by 2027), UCB Pharma (SPOON study on myasthenia gravis), and Biogen (NewPerSEPtion study on multiple sclerosis). The platform reports 600,000+ patients involved, 20M+ data points collected, and 60+ peer-reviewed scientific publications.

The business model combines SaaS subscriptions for the SKEZIA and SKEMEET platforms (with tiered service levels and the SKEZIA+ enhanced-service offering) and professional services for study design, regulatory compliance, and implementation. Distribution is hybrid: direct enterprise sales to hospitals, pharma and academic institutions, plus a self-serve free-beta access channel for smaller researchers, associations, and individual clinicians. The company is headquartered in Annecy with a Paris office, has 11–50 employees, and is privately held; the only disclosed funding event is a Bpifrance round of approximately $2.73M in November 2024, supplemented by EU co-funding.

Skezi firmographics

Firmographics
Name
Skezi
Legal name
SKEZI
Website
https://skezi.eu
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
SKEZI is a French health-data SaaS provider, spun out of AP-HP and Université Paris-Cité in 2020, offering a sovereign, HDS-certified platform (SKEZIA) for e-cohort management, PROMs/PREMs collection, and patient-reported research serving hospitals, academics, pharma, and patient associations.
Ownership category
akta.pro rank

Skezi industry classification

Industry
Product category
Clinical Research Software (Health Data Collection & E-Cohort Management)
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLACAOAB
eCOA/ePRO/eDiary & Patient-Facing Data Collection
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)

Keywords

  • Clinical research software
  • Health data collection
  • Electronic patient cohorts
  • Patient reported outcomes
  • Tele-expertise platform

Where Skezi is headquartered

Location

Headquarters

HQ city
Annecy
HQ country
France
HQ region
Europe

Offices3 records

Markets served

Skezi business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Software Subscriptions (SKEZIA/SKEMEET): SaaS platform subscriptions for data collection, e-cohort management, and tele-expertise services with tiered service levels
  2. Professional Services: Expert support for study design, regulatory compliance, and implementation assistance for healthcare research projects
  3. SKEZIA+ Service: Enhanced service offering with individualized support for complex data collection projects

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Skezi product offering

Product offering

Core offering

Skezi (commercial name: SKEZI) sells the SKEZIA SaaS platform, a sovereign French health data collection solution that enables clinical researchers, healthcare institutions, pharmaceutical companies, and patient associations to build and manage electronic patient cohorts (e-cohorts) and collect patient-reported outcomes (PROMs/PREMs) via customizable questionnaires. The company complements SKEZIA with SKEMEET tele-expertise software, SKETHIS quality-of-life observatory services, and Verbatim.Care NLP-based patient verbatim analysis.

Product overview

SKEZI offers a suite of e-health data collection solutions centered around its core platform SKEZIA. SKEZIA is the primary sovereign SaaS product for collecting secure health data via questionnaires, managing e-cohorts, and supporting PROMs/PREMs collection. This core platform is complemented by SKEMEET (formerly ShareConfrère), a tele-expertise platform for expert consultations and multidisciplinary meetings; Verbatim.Care, an NLP-powered patient verbatim analysis platform acquired from EntendsMoi; and SKETHIS, a quality-of-life observatory initiative. Together, these products form a 360° health data collection ecosystem spanning clinical research, routine care, patient experience, and public health monitoring.

Differentiator

Problem solved

Functional benefit

Brands

  • SKEZIA: Platform for collecting sensitive and secure health data via questionnaires, including e-cohort management and survey tools.
  • SKEMEET
  • SKETHIS
  • Verbatim.Care

Quantifiable outcome

  • 600,000+ patients involved in platform studies
  • +3 more outcomes

Companies that use Skezi

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles3 records

Skezi technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Skezi partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered core, strategic and minor.

  • INRAEcoreStrategic or Co-development Partner · 16 October 2023SKEZI deploying SKEZIA for Le French Gut national project, aiming to collect microbiome samples and data from 100,000 volunteers by 2027 to map French gut microbiota and understand chronic disease interactions
  • Université Paris-CitécoreStrategic or Co-development PartnerCo-founding partner of SKEZI spin-off, continuing development of ComPaRe cohort technology and academic research collaboration
  • WithingsstrategicTechnology or IntegrationPartnership for remote patient monitoring combining Withings connected health devices with SKEZI data collection platform for hypertension management, enabling pharmacists to relay patient data
  • OVHcloudstrategicGTM or Marketing PartnerSKEZI joined OVHcloud Startup Program for one year, receiving infrastructure support and recognition as Health Startup of the Year 2022
  • OctopizestrategicTechnology or IntegrationPartnership for data anonymization using Octopize's unique technology to protect SKETHIS community data while preserving useful information for research
  • Hack Your CareminorGTM or Marketing PartnerPartnership for recruiting professionals with scientific and medical competencies to support SKEZI team growth
  • France ReinstrategicStrategic or Co-development PartnerPartnership with leading kidney disease patient association to accelerate research and care evaluation using SKEZIA for data collection and e-cohort monitoring
  • Club des Jeunes Néphrologues (CJN)minorStrategic or Co-development PartnerPartnership enabling all CJN members to access SKEZIA for independent studies and data collection to accelerate kidney disease research
  • AGORiA SantéminorStrategic or Co-development PartnerPartnership to improve healthcare through better health data exploitation, accelerating patient-reported data collection for AGORIA's health data warehouse
  • UCB PharmastrategicStrategic or Co-development PartnerPharmaceutical partner for SPOON study on generalized myasthenia gravis, funded by UCB to understand patient quality of life and treatment expectations
  • BiogenstrategicStrategic or Co-development PartnerNewPerSEPtion study on perceived value of natalizumab treatment in multiple sclerosis patients, with SKEZI handling regulatory documents, data collection platform, and analysis
  • ISART DigitalminorStrategic or Co-development PartnerStrategic partnership with gaming/animation school to integrate gamification into e-health solution, making data collection more engaging
  • SOS HépatitesminorStrategic or Co-development PartnerCo-construction of patient feedback collection and liver disease research, including 'Juin sans sucres ajoutés' initiative
  • Alliance PEP SantéminorStrategic or Co-development PartnerPartnership with national healthcare platform supporting patient and caregiver accompaniment through SKEZIA availability
  • EntendsMoi (Verbatim.Care)strategicTechnology or IntegrationAcquisition of EntendsMoi platform (Verbatim.Care) in December 2024 to strengthen SKEZIA with patient verbatim analysis and NLP capabilities
  • AP-HPcoreStrategic or Co-development PartnerCo-founding partner and primary research institution behind ComPaRe and ESPERES cohorts, largest hospital system in Europe

Scale indicators6 records

Recent moves7 records

Expansion highlights7 records

Skezi competitors and assessment

Company assessment

Regional players

  • Doctolib: Doctolib is the dominant French health-tech platform used by hospitals and physicians; it is not a direct eCOA competitor but shapes the French procurement landscape in which SKEZI sells its interoperable e-health platform.

Broad incumbents

  • Clario: Clario (formerly ERT/Bioclinica) is a large incumbent in clinical trial endpoint technology, including eCOA — providing the bundled alternative SKEZI competes against for hospital and pharma trials.
  • Cegedim: Cegedim is a French health-data and clinical-research software incumbent (THINK, Clinityx) operating across real-world evidence and hospital information systems — overlapping with SKEZI's hospital interoperability play.
  • Medidata (Dassault Systèmes): Medidata's Rave platform bundles EDC, eCOA, and patient-reported outcomes in one enterprise stack, making it the dominant broad incumbent competing for the same pharma-sponsored PRO data workloads.

Direct peers

  • Signant Health: Signant Health is a global eCOA/ePRO specialist focused on patient-reported outcomes in clinical trials — the same core problem SKEZI addresses, with deeper enterprise pharma coverage.
  • Castor: Castor is a direct competitor in eCOA/ePRO and electronic data capture for clinical trials, offering a self-service clinical research platform widely adopted by academic and commercial sponsors — directly overlapping SKEZI's SKEZIA offering.

Emerging players

  • THREAD: THREAD is a decentralized clinical trial platform with eCOA/ePRO modules — overlapping SKEZI's decentralized patient data collection, though focused on global pharma rather than French institutional cohorts.
  • Alira Health: Alira Health provides patient-centric real-world evidence and outcomes services for medtech and pharma — overlapping SKEZI's PRO/ePRO-based evidence generation value proposition.
  • Owkin: Owkin is a French health-AI company working on real-world patient data for research — thematically adjacent to SKEZI's cohort and RWE focus within the French health-data ecosystem.
  • Curebase: Curebase runs decentralized and hybrid clinical trials with built-in ePRO/eCOA, an emerging alternative for sponsors comparing site-less trial designs against e-cohort-based approaches like SKEZIA.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks4 records

Key highlights6 records

Customer concentration

Skezi social profiles

Digital presence

Skezi compliance and trust

Trust signal

Compliance1 record

Skezi financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Skezi leadership team

Management profile

Number of profiles

Profiles3 records

Skezi subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Skezi funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Skezi M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Skezi

What does Skezi do?

Skezi (commercial name: SKEZI) sells the SKEZIA SaaS platform, a sovereign French health data collection solution that enables clinical researchers, healthcare institutions, pharmaceutical companies, and patient associations to build and manage electronic patient cohorts (e-cohorts) and collect patient-reported outcomes (PROMs/PREMs) via customizable questionnaires. The company complements SKEZIA with SKEMEET tele-expertise software, SKETHIS quality-of-life observatory services, and Verbatim.Care NLP-based patient verbatim analysis.

Is Skezi a public or private company?

Skezi is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Skezi founded?

Skezi was founded in 2020. It employs 11 to 50 people.

Where is Skezi based?

Skezi is headquartered in Annecy, France, in the Europe region.

How does Skezi make money?

Three revenue lines are on record. Software Subscriptions (SKEZIA/SKEMEET) is the primary driver. The others are professional Services and SKEZIA+ Service.

Who are Skezi's main competitors?

Doctolib is listed as a regional player. Broad incumbents are Clario, Cegedim and Medidata (Dassault Systèmes). Direct peers are Signant Health and Castor. Emerging players are THREAD, Alira Health, Owkin and Curebase.

Does Skezi have an API?

Yes. SKEZI announced the deployment of its API to make SKEZIA interoperable with all healthcare software in the hospital environment. This enables SKEZIA to connect with hospital information systems for streamlined data collection. No further technical details (REST/GraphQL, authentication, rate limits, versioning, sandbox) are publicly specified.

What industry is Skezi in?

Skezi's product category is Clinical Research Software (Health Data Collection & E-Cohort Management). Its primary akta.pro industry code is HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection, with a secondary code of HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 5417 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales